EANS-Adhoc: - Axel Hölzer stepping down as Chairman of the Marseille-Kliniken AG Management Board for health reasons with immediate effect - Supervisory Board Chairman Ulrich Marseille temporarily appointed acting Chairman of the Management Board
-------------------------------------------------------------------------------- ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------------
05.03.2010
Berlin, 5 March 2010. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) is announcing: Axel Hölzer is stepping down from his post as the company´s Chairman of the Management Board with immediate effect. This is due to the fact that Mr. Hölzer is suffering from a serious illness, which will require longer treatment. Mr. Hölzer today asked the Supervisory Board to relieve him from his duties, which the Supervisory Board complied with. Mr. Hölzer also resigned from all other board roles connected to Marseille-Kliniken Group. As a consequence of this unexpected development, the Supervisory Board has appointed the company-founder and current Chairman of the Supervisory Board Ulrich Marseille to the Management Board for a period of six months in line with Section 105, Paragraph 2 of the German Stock Corporation Act. Ulrich Marseille will be assuming a coordinating role on the Management Board. Uwe Bergheim, member of the Supervisory Board of Marseille-Kliniken AG, will be the acting Chairman of the Supervisory Board for this period of time. These circumstances will not have an impact on the development of Marseille-Kliniken AG´s revenues and profitability.
Axel Hölzer has served Marseille-Kliniken AG since 1995 and held a variety of positions in finance. In 1999, he was appointed to the Management Board, initially responsible for associated companies, taking over as CFO in 2000. In 2002, he was appointed Chairman of the Management Board. His tenure was driven by expanding the Care business as well as restructuring and preparing the sale of the Rehabilitation facilities. The Supervisory Board appreciates Mr. Hölzer´s decision and would like to thank him for the successful cooperation in the past years and wishes him the best for his recovery and his personal future.
End of ad hoc release
end of announcement euro adhoc --------------------------------------------------------------------------------
Further inquiry note:
Hillermann Consulting
Christian Hillermann
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114
www.hillermann-consulting.de
;
Marseille-Kliniken AG
Dr. Ute Buchheim
Friedrich-Ebert-Str. 65
33330 Gütersloh
Germany
Tel.: +49-(0)5241/90 39-35
Fax: +49-(0)5241/90 39-39
www.marseille-kliniken.com
Branche: Pharmaceuticals
ISIN: DE0007783003
WKN: 778300
Index: CDAX, Classic All Share, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hamburg / regulated dealing
Original-Content von: Marseille-Kliniken AG, übermittelt durch news aktuell